Taken together our findings suggest that the reduced expression of the anti-apoptotic protein survivin is a major mechanism by which SINE exert their anti-tumor activity and provide a rationale basis for offering treatment of DMPM with SINE. This evidence concerns the gene BIRC5 and neoplasm.